Identification and functional characterization of a novel arginine/ornithine transporter, a member of a cationic amino acid transporter subfamily in the Trypanosoma cruzi genome by Henriques, C et al.
Henriques et al. Parasites & Vectors  (2015) 8:346 
DOI 10.1186/s13071-015-0950-yRESEARCH Open AccessIdentification and functional characterization
of a novel arginine/ornithine transporter, a
member of a cationic amino acid transporter
subfamily in the Trypanosoma cruzi genome
Cristina Henriques1,5,6*, Megan P. Miller3, Marcos Catanho4, Técia Maria Ulisses de Carvalho5, Marco Aurélio Krieger8,
Christian M. Probst8, Wanderley de Souza5,6,7, Wim Degrave4 and Susan Gaye Amara2,3Abstract
Background: Trypanosoma cruzi, the etiological agent of Chagas disease, is auxotrophic for arginine. It obtains this
amino acid from the host through transporters expressed on the plasma membrane and on the membranes of
intracellular compartments. A few cationic amino acid transporters have been characterized at the molecular level,
such as the novel intracellular arginine/ornithine transporter, TcCAT1.1, a member of the TcCAT subfamily that is
composed of four almost identical open reading frames in the T. cruzi genome.
Methods: The functional characterization of the TcCAT1.1 isoform was performed in two heterologous expression
systems. TcCAT subfamily expression was evaluated by real-time PCR in polysomal RNA fractions, and the cellular
localization of TcCAT1.1 fused to EGFP was performed by confocal and immunoelectron microscopy.
Results: In the S. cerevisiae expression system, TcCAT1.1 showed high affinity for arginine (Km = 0.085 ± 0.04 mM)
and low affinity for ornithine (Km = 1.7 ± 0.2 mM). Xenopus laevis oocytes expressing TcCAT1.1 showed a 7-fold
increase in arginine uptake when they were pre-loaded with arginine, indicating that transport is enhanced by
substrates on the trans side of the membrane (trans-stimulation). Oocytes that were pre-loaded with [3H]-arginine
displayed a 16-fold higher efflux of [3H]-arginine compared with that of the control. Analysis of polysomal RNA
fractions demonstrated that the expression of members of the arginine transporter TcCAT subfamily is upregulated
under nutritional stress and that this upregulation precedes metacyclogenesis. To investigate the cellular localization of
the transporter, EGFP was fused to TcCAT1.1, and fluorescence microscopy and immunocytochemistry revealed the
intracellular labeling of vesicles in the anterior region, in a network of tubules and vesicles.
Conclusions: TcCAT1.1 is a novel arginine/ornithine transporter, an exchanger expressed in intracellular compartments
that is physiologically involved in arginine homeostasis throughout the T. cruzi life cycle. The properties and estimated
kinetic parameters of TcCAT1.1 can be extended to other members of the TcCAT subfamily.
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Protozoans have the capacity to synthesize only a few
amino acids; thus, they depend on external sources to
supply them with amino acids, the transport of which is
mediated by several plasma membrane carriers. De novo
synthesis of amino acids is restricted to those produced
via short pathways or those derived from metabolic
intermediates of glycolysis, the citric acid cycle, or the
pentose phosphate pathway [1, 2]. Arginine biosynthesis
does not occur in the parasite Trypanosoma cruzi, which
lacks the enzymes argininosuccinate lyase and arginino-
succinate synthase, which are responsible for recycling
citrulline to arginine [3, 4]. Consequently, arginine is
acquired from the host through biochemically character-
ized high- and low-affinity transport systems on the
parasite plasma membrane [5, 6].
T. cruzi is an intracellular and highly invasive patho-
gen transmitted by bloodsucking insects of the subfamily
Triatominae. The metacyclic trypomastigote forms re-
leased with vector excrement next to the bite wound can
infect nearly all tissues [7], and upon entry into cells,
they transform into replicative amastigotes. After several
cycles of binary division, they then transform into trypo-
mastigotes, which are released into the bloodstream.
Bloodstream trypomastigotes within mammalian hosts
can be taken up by bloodsucking insects and trans-
formed into epimastigotes, which replicate in the insect
midgut and then develop into pathogenic metacyclic
trypomastigote forms [8, 9]. Several intermediate stages
are completed, but the primary developmental stages in
the T. cruzi life cycle involve the epimastigote, amasti-
gote, and infective trypomastigote forms [10, 11].
Arginine requirements can vary according to fluctuat-
ing biochemical needs specific to each stage of the para-
site’s life cycle. In T. cruzi, L-arginine is involved in the
production of nitrous oxide, high-energy phosphate
compounds and protein biosynthesis. However, the
protozoan lacks the enzymes: (i) arginase, which con-
verts L-arginine to L-ornithine and urea; (ii) ornithine
decarboxylase; and (iii) arginine decarboxylase. Thus,
T. cruzi is auxothophic for polyamines and there is no
evidence of the urea cycle in T. cruzi [12–14]; therefore,
the amidino group of amino acids can be transferred to
amino acceptors to form guanidine derivatives, which
can be phosphorylated by kinases, generating high-
energy phosphate compounds [15, 16]. In T. cruzi,
arginine can be phosphorylated by arginine kinase, pro-
ducing phosphoarginine, a specific phosphagen and
high-energy phosphate compound [17, 18] involved in
cell energy storage and in pH and nutritional stress
response mechanisms [19]. Arginine kinase is not
expressed in mammalian tissues, but in this parasite, it is
an important enzyme for arginine metabolism that is
inhibited by several arginine analogs. However, to date,only canavanine and homoarginine have been shown to
significantly inhibit T. cruzi epimastigote growth [18, 20].
The fate of L-arginine in this pathogen likely depends
on L-arginine availability, the regulation of metabolic
enzymes, and the expression of specific transporters.
After crossing the protozoan plasma membrane, arginine
can enter into intracellular compartments, such as the
acidocalcisome, an organelle enriched in cationic amino
acids and polyphosphates [21, 22]. Transporters carry
out their functions in a variety of membrane compart-
ments, mediating the efflux and influx of molecules and
ions and playing roles in osmotic and membrane poten-
tial regulation in protozoans [22–24]. The identification
of 60 unique sequences encoding putative amino acid
transporters [25] in the T. cruzi genome is indicative of
the complexity of these proteins and their relevance to
cell physiology and metabolism. Despite their import-
ance, few amino acid transporters have been character-
ized at the molecular level in trypanosomatids [26–30].
Here, we report the molecular and functional charac-
terization of a novel arginine/ornithine transporter from
T. cruzi using heterologous systems. TcCAT1.1 is a
member of a subfamily of cationic amino acid trans-
porters, TcCAT, which is composed of four open reading
frames (ORFs) in the T. cruzi CL Brener genome. The
trans-stimulation property of TcCAT1.1 was examined
in Xenopus laevis oocytes, and the kinetic parameters of
transport were analyzed in a Saccharomyces cerevisiae
null mutant lacking cationic amino acid transporters
[31], which is a versatile expression system that allows
for efficient drug screening. Quantification of the expres-
sion of TcCAT subfamily members was performed
throughout the T. cruzi life cycle using quantitative PCR
(qPCR). Intracellular localization of this transporter in a
network of tubules and vesicles at the anterior region of
the protozoan suggests that it plays a role in the trans-




Trypanosoma cruzi epimastigotes, wild-type (Dm28c-WT)
and genetically modified parasites expressing EGFP
(Dm28c-EGFP) or EGFP-TcCAT1.1 (Dm28c-EGFP-Tc-
CAT1.1), were cultivated in liver infusion tryptose (LIT)
medium at 28 °C until the logarithmic stage of growth
[32] (Camargo, 1964). The non-infective and replicative
epimastigotes were transformed into non-dividing and
infective metacyclic trypomastigotes. The process re-
ferred to as metacyclogenesis was triggered by exposing
T. cruzi epimastigotes, at the late exponential growth
phase and a cell density of 3 × 107 cells/ml, to nutri-
tional stress by incubation in triatomine artificial urine
(TAU) medium containing 190 mM NaCl, 8 mM
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for 2 h and further incubation for 5 days in TAU supple-
mented with amino acids and glucose (TAU3AAG;
0.035 % sodium bicarbonate, 10 mM L-proline, 50 mM
sodium glutamate, 2 mM sodium L-aspartate, and 10
mM glucose) [11]. Metacyclic parasites were used to
infect LLC-MK2 cells, and trypomastigotes released
from these cells were used to infect mice. Amastigotes
were prepared as described [33].
Infection rate
LLC-MK2 cells were placed on 13 mm round glass cover
slips in a 24 well microplate and maintained for 18 h in
RPMI 1640 medium supplemented with 5 % FBS at 37 °C
in a 5 % CO2 atmosphere. Then, the cells were washed
and exposed to trypomastigotes of Dm28c-WT, Dm28c-
EGFP, or Dm28c-EGFP-TcCAT1.1, maintaining a parasi-
te:host cell ratio of 10:1, in 200 μl of RPMI at 37 °C and
5 % CO2. After 4 h, infected cultures were washed to re-
move non-internalized parasites and maintained for 24, 48
or 72 h in RPMI 1640 medium supplemented with 5 %
FBS at 37 °C in a 5 % CO2 atmosphere. Infected cells were
fixed with Bouin’s solution, washed with 70 % ethanol,
washed again with water and stained with Giemsa. Subse-
quently, cover slips were successively dehydrated in the
following acetone–xylol mixtures: (1) 100 % acetone; (2)
70 % acetone–30 % xylol; (3) 30 % acetone–70 % xylol;
and (4) 100 % xylol. Next, the cover slips were mounted
and sealed onto slides with Entelan® (Merck). The rate of
infection and number of parasites per infected cell were
quantified in at least 500 cells using a light microscope
(Leica Microsystems). Two independent experiments were
performed in triplicate.
Animals and infection
Seven-week-old male BALB/c mice were obtained from the
Animal Laboratory Breeding Center at Fundação Oswaldo
Cruz (CECAL) and housed for 7 days at the Laboratory of
Cellular Ultrastructure-UFRJ under the environmental and
sanitary conditions established in the guide for the Care
and Use of Laboratory Animals (DHEW publication No.
[NIH] 80–23). This project was approved by the Biophysics
Institution Committee of Ethics in Animal Research
(IBCCF106) according to resolution 196/96 of the National
Health Council of the Brazilian Ministry of Health. The
experimental groups consisted of BALB/c mice intraperi-
toneally infected with 105 Dm28c-WT, Dm28c-EGFP, or
Dm28c-EGFP-TcCAT1.1 trypomastigotes. Parasitemia was
determined in 5 μl of blood obtained from tail snips
according to the method of Pizzi-Brenner.
BLAST search and PCR amplification of TcCAT sequences
To clone putative TcCAT transporter genes, basic local
alignment search tool (BLAST) searches [34, 35] wereperformed using amino acid transporter protein sequences
from S. cerevisiae, Homo sapiens and other organisms
compiled from the National Center for Biotechnology In-
formation (NCBI) in a query against a T. cruzi CL Brener
predicted protein sequence database [http://www.tigr.org/
tdb/e2k1/tca1/]. Candidate amino acid transporters from
T. cruzi that shared ≥ 20 % identities with the query
sequences and showed ≥ 60 % alignment along the query
or hit sequences and an e-value of ≤ 10−5 were selected
using the software BioParser [36]. The putative amino acid
transporter sequences were grouped using CLUSTALW
(polydot program), generating approximately 11 groups.
The TcCAT subfamily was composed of 4 ORFs distrib-
uted in three contigs, according to the GeneDB database
[http://www.genedb.org].
The corresponding T. cruzi TcCAT coding sequences
were amplified from genomic DNA by polymerase chain
reaction (PCR) with Platinum Taq DNA Polymerase
High Fidelity (Invitrogen). The forward primer included
the EcoRI restriction site (underlined) and Kozak se-
quence (italics) (5’CGG AAT TCC GCC ACC ATG
GAC ACC GAG AGT GGC AAT 3’). The reverse pri-
mer contained the XhoI restriction site (underlined) and
COOH-terminal region of the ORF (5’ CCG CTC GAG
CGG TTA CCG AAC CAC ACC ATA CAG GCT 3’).
The resulting PCR-amplified fragment was cloned into a
pBAD TOPO TA vector (Invitrogen). The following oli-
gonucleotides were designed for automated sequencing:
(1) 5’ GGC TTT CAG ATG AGT GGT GTC 3’; (2) 5’
CAA TCG CGC GGT GAC AAG TGC 3’; (3) 5’ CGA
GCG CGA GGC GCA TGA CGC 3’; and (4) 5’ TTG
CCT TTT CTG TGG AGT TAT; and the reverse oligo-
nucleotide (5) 5’ GAC ACC ACT CAT CTG AAA GCC
3’(Invitrogen). Automated sequencing was performed
with an ABI Prism® 310 Genetic Analyzer (Applied Bio-
systems) at the Department of Neurobiology, University
of Pittsburgh.
Polysomal RNA Purification
T. cruzi polysomes, purified from Dm28c-WT epimasti-
gotes and other life cycle forms, were used for qPCR
and microarray analysis. Polysomal RNA was extracted
from replicating epimastigotes, from parasites incubated
for 2 h in TAU medium, which introduced nutritional
stress and triggered in vitro metacyclogenesis, and from
differentiating parasites incubated in TAU3AAG medium
for 3 h, 12 h, 24 h, or 5 days to produce metacyclic try-
panosomes. Epimastigotes, other life cycle forms, and
metacyclic parasites were centrifuged at 2000 g for 20 min
at 4 °C and washed three times with NKM buffer, com-
posed of 140 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, and
10 mM Hepes, pH 7.4. Next, parasites were lysed with
buffer A, composed of 300 mM KCl, 10 mM MgCl2, 10
mM Tris–HCl, pH 7.4, 10 % Nonidet P-40 and 2 M
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at 4 °C. To obtain the post-mitochondrial fraction, the
supernatant was again centrifuged at 16,000 g for 30 min
at 4 °C and layered onto 15 to 55 % sucrose density gradi-
ents prepared in buffer B, composed of 300 mM KCl, 10
mM MgCl2, 10 mM Tris–HCl, pH 7.4, 100 μg/ml cyclo-
heximide, 10 μM E-64, 1 mM phenylmethylsulfonyl fluor-
ide, and 1 mg/ml heparin, and centrifuged at 200,000 g for
2 h. The pellet containing the polysomal fraction was col-
lected, and RNA was extracted by the hot phenol method
and with saturated phenol. Samples containing purified
RNA were concentrated by precipitation with one volume
of 10 % isopropanol and 3 M sodium acetate, purified with
an RNAeasy kit (Qiagen) and stored in liquid nitrogen.
Relative quantification of TcCAT by real-time PCR (qPCR)
Initially, RNA was amplified due to the low yield of
RNA obtained from the polysomal fractions of some T.
cruzi life stages. Amplified RNA was generated from 1
μg of polysomal RNA and oligo (dT) primers coupled to
the T7 promoter (US Biochemical Corp.) using a Messa-
geAmp™ aRNA Amplification Kit (Ambion), according
to the manufacturer's instructions. Thereafter, cDNA
was synthesized from 1 μg of cRNA by incubation with
400 mM of random primers, RT buffer, dNTPs and re-
verse transcriptase (IMPROM II, Promega), according to
the manufacturer’s recommendations, for 2 h at 42 °C.
cDNA was purified and concentrated using a Microcon
YM-30 filter (Millipore).
Real-time PCR was performed with a 7500 Real-Time
PCR System (Applied Biosystems), and the results were
normalized by expression of L9 ribosomal protein and
histone H2B, which were amplified with the following
primers: TcL9F (5` CCTTCACTGCCGTTCGTTGGTT
TG 3`); TcL9R (5` ATGCGAGAGTGCCGTGTTGAT
3`); and TcH2BF (5` CGGTGGTGCGCGTCAACAAG
AAGC 3`); TcH2BR (5` CCAGGTCCGCCGGCAGC
ACGAG 3`), respectively. PCR was performed in a
20–25 μL reaction mixture containing 10 ng cDNA and
the recommended amount of SYBR Green Master Mix
(Applied Biosystems). All reactions contained 4 pmol of
specific primers (TcCATf 5'-CATCATTGGATGGGA
TGTGG-3' and TcCATr 5'-ATAAAGAGCCCGAGCA
GCAG-3'). The PCR conditions were as follows: 10 min
at 95 °C, followed by 45 cycles at 95 °C for 15 s, 60 °C
for 30 s and 72 °C for 1 min. For SYBR Green-based
assay, melting curve analysis was performed after ampli-
fication to ensure that the correct product had been ob-
tained by determining its specific melting temperature.
The real-time PCR efficiency rate in the investigated
range of 5 to 625 ng cDNA (n = 3) was calculated as fol-
lows, and was found to exhibit high linearity (r > 0.95):
for TcH2B, 2.0 (slope −3.313618); for TcL9, 2.05
(slope −3.210819); and for TcCAT transporter, 1.97(slope −3.405488). Relative gene expression was deter-
mined using the 2 -ΔΔCT method [37].
Expression of TcCAT1.1 in Saccharomyces cerevisiae
The TcCLB.506153.10 ORF, TcCAT1.1, was excised from a
pBAD TOPO TA vector with EcoRI and XhoI restriction
digestion and subcloned into the same sites of a galactose
inducible yeast expression vector, pYES2 (Invitrogen).
Saccharomyces cerevisiae strain HSC100-3C (ATCC#
201221) (MATα can1 gap1 lyp1 ura3Δ) was trans-
formed with plasmid DNA using a Yeastmaker Yeast
transformation system 2 (Bioscience Clontech). Trans-
fected yeasts were selected on 1.5 % agar minimal
medium plates without uracil and with glucose and
amino acid supplementation as required. Selected col-
onies were cultivated overnight in liquid minimal
medium containing 2 % galactose to induce TcCAT1.1
expression or 2 % glucose as a control. Thereafter, the
cells were incubated overnight at 30 °C until they
reached an OD600 of 0.2, centrifuged at 3000 g for 10
min, transferred to new medium and grown to mid-log
phase. The cells were centrifuged at 3000 g for 10 min,
the excess liquid was drained, and cellular density was
adjusted to an OD600 of 2 in the appropriate buffer.
Uptake assays were performed by adding 200 μl of cell
suspension (OD600 = 2) to a 200 μl aliquot of substrate
concentrated two-fold. Following incubation for the re-
quired period of time, uptake was stopped by addition of
3 ml of cold water and immediate filtration through a
nitrocellulose filter with a pore size of 0.45 μm (Millipore).
The tube was washed twice with 3 ml of cold water, and
the filter apparatus was washed three times. The radio-
activity retained in the filter was quantified with a liquid
scintillation counter (Wallac 1400).
Substrate saturation curves were obtained by incuba-
tion of induced and repressed yeast cells with increasing
concentrations of [3H]-arginine or [14C]-ornithine sub-
strates (Perkin-Elmer Reagents). The incubation time
required for uptake was found to be within the linear
range. Apparent Km and Vmax values were calculated by
non-linear regression analysis and fitted to the Michaelis-
Menten equation (SigmaPlot software, SPSS Science).
Substrate competition assays were performed with a 100-
fold concentration of competitor relative to that of sub-
strate. The optimal pH range for [3H]-arginine uptake was
achieved in Krebs buffer without glucose, composed of
146 mM NaCl, 5 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2,
5 mM HEPES and 5 mMMES.
Expression of TcCAT1.1 in Xenopus laevis oocytes
The TcCAT1.1 ORF was restriction digested from a pYES2
vector and subcloned into the KpnI and XbaI restriction
sites of an oocyte transcription vector, pOTV2-8 [38], to
generate a pOTV2-8/TcCAT1.1 plasmid. After linearization
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T7 RNA polymerase (Life Technologies, Inc.). Stage V-VI
Xenopus laevis oocytes were injected with 23 nl of cRNA
(~10 ng) or water as a control and incubated in ND96
buffer, 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2 and 5 mM Hepes, pH 7.5, for 3 days at 16 °C.
Uptake of radiolabeled compounds was performed in
ND96 buffer. Oocytes were dissolved with 10 % SDS and
subjected to liquid scintillation counting. For each data
point, the pmoles of internalized labeled substrate were
calculated and plotted as a function of incubation time.
Trans-stimulation assays were performed using
TcCAT1.1-expressing cRNA-injected oocytes and water-
injected oocytes preloaded with 1 mM or 10 mM arginine
overnight or after 6 h incubation, respectively. Thereafter,
the oocytes were washed twice in ND96 buffer at 4 °C and
incubated with [3H]-arginine at room temperature for up-
take assays. For efflux measurements, oocytes preloaded
overnight or for 6 h with 1 μM [3H]-arginine were washed
twice in ND96 buffer at 4 °C and immediately transferred
to ND96 buffer (0.5 ml) to allow for the efflux of radiola-
beled compounds. After incubation for the required
period of time, an aliquot of incubation buffer was exam-
ined in a scintillation counter and the total amount of ra-
diolabel in the buffer was divided by the number of
oocytes per well.
Expression of EGFP-TcCAT1.1 fusion protein in
Trypanosoma cruzi
To fuse EGFP with the TcCAT1.1 transporter at the
NH2-terminus, TcCAT1.1 was subcloned into an inte-
grative pTREX vector at the BstXI and XhoI restriction
sites [39]. Thereafter, a second digestion of the TcCAT1.1-
pTREX construct was performed using XbaI and EcoRI to
subclone the EGFP cleaved with NheI and EcoRI from a
pEGFPC1 vector (Invitrogen), generating pTREX/EGFP-
TcCAT1.1. The EGFP-N-terminal TcCAT1.1 fusion con-
struct was sequenced with an ABI 3730 Genetic Analyzer
(Applied Biosystems), using the Fiocruz sequencing plat-
form [40]. As a control, EGFP was cleaved from a pEGFP
vector with the NheI and XhoI enzymes (Invitrogen) and
cloned in the XbaI and NotI restriction sites of pTREX.
T. cruzi epimastigotes of the Dm28c or Y strain were
suspended at 1 × 108 cells/ml in electroporation buffer
(EPB) containing 137 mM NaCl, 5 mM KCl, 0.7 mM
Na2HPO4, 6 mM glucose, and 21 mM HEPES, pH 7.3.
The cellular suspension (400 μl) was mixed with 50 μg
of plasmid, placed in a 0.2 cm cuvette and subjected to a
pulse of 0.45 kV and 500 μF at room temperature using
a Gene Pulser apparatus (BioRad Laboratories) [41]. The
cells were re-suspended in LIT medium, and G418 (100
μg/ml) was added at 24 h after transfection. The G418
level was increased from 200 to 500 μg/ml to select
stable transformants. Then, epimastigote cloning wasperformed by serial dilutions in a 96 well plate, and clones
were evaluated by fluorescence microscopy (Axyoplan,
Carl Zeiss).
Transport Assays of Trypanosoma cruzi expressing
EGFP-TcCAT1.1 fusion construct
[3H]-arginine uptake was assessed in two clones of
Dm28c-EGFP-TcCAT1.1, Dm28c-EGFP, and Dm28c-
WT. Epimastigotes were centrifuged at 1500 g for 10
min and washed once with Krebs buffer composed of
146 mM NaCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 5 mM
KCl, and 5 mM HEPES, pH 6.8. After centrifugation at
1500 g for 10 min, the excess liquid was drained, and
parasite density was adjusted to 108 epimastigotes/ml in
Krebs buffer. [3H]-arginine (Perkin Elmer) at a specific
activity of 50 Ci/mmol was prepared in Krebs buffer and
diluted with cold arginine to achieve the specific activity
desired for the various experiments.
Uptake assays were initiated by adding 100 μl of para-
site suspension (107 epimastigotes) to a 100 μl aliquot of
two-fold-concentrated [3H]-arginine for a total volume
of 200 μM in a 5 ml tube. Following incubation for 15,
30, 60, or 120 min at room temperature and for 30 sec
(0.5 min) on ice (binding), uptake was stopped with 3 ml
of cold phosphate-buffered saline (PBS), and the suspen-
sion was immediately filtered through a nitrocellulose
filter with a pore size of 0.45 μm (Millipore). The tube was
washed twice, and the filter apparatus was washed once.
The radioactivity retained in the nitrocellulose filter was
quantified with a liquid scintillation counter (Packard
Tricarb) in 2.5 ml of scintillation liquid (Optiphase
HiSafe, Perkin Elmer). Three independent assays were
performed in triplicate.
Subcellular localization of TcCAT1.1 in Trypanosoma cruzi
epimastigotes
Dm28c-EGFP, Dm28c-EGFP-TcCAT1.1 and Dm28c-WT
were centrifuged at 1500 g for 15 min at 4 °C, washed
twice with PHEM buffer composed of 5 mM MgCl2, 70
mM KCl, 10 mM ethyleneglycol-bis-(β-aminoethylether)-
N,N,N`,N`-tetraacetic acid, 20 mM Hepes, and 60 mM
Pipes, pH 7.3, fixed with 4 % paraformaldehyde in PHEM
buffer for 15 min on ice, allowed to attach to cover slips
that were coated with 0.1 % poly-L-lysine (Sigma), perme-
abilized in 100 % methanol at −20 °C for 5 min, and
blocked with 50 mM NH4Cl and 1 % BSA in PHEM buffer
at room temperature for 30 min. Then, further incubation
was performed for 1 h with the following primary anti-
bodies diluted in blocking buffer: (1) anti-rabbit PPase
(1:200), a vacuolar-type proton-pumping pyrophosphatase;
(2) anti-rabbit TcRAB7 (1:20) [42]; and (3) anti-mouse
GFP (1: 200). After three washes with blocking buffer, the
slides were incubated with Alexa Fluor 546-conjugated
goat anti-rabbit IgG or Alexa Fluor 546-conjugated anti-
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rature for 1 h and washed three times with blocking buffer
and once with PBS. Finally, the nuclei and kinetoplasts
were stained with DAPI (5 μg/ml) for 10 min. Cover slips
were washed four times with PBS, mounted onto slides
and observed using a LEICA TCS-SP5 Confocal Laser
Scanning Microscope (CLSM, Leica Microsystems). A
lambda scan was performed with a 488 nm or 546 nm
wavelength, and images were acquired using 5 nm band-
width increments from 500 to 700 nm.
Endocytosis in Trypanosoma cruzi epimastigotes
Dm28c epimastigotes expressing EGFP-TcCAT1.1 were
centrifuged at 1500 g for 10 min and washed with
DMEM medium. Thereafter, the parasites were diluted
to 107/ml in DMEM medium and starved for 30 min at
28 °C, followed by a 10 min incubation on ice. Endo-
cytosis assays were performed by incubation of 107 epi-
mastigotes with human transferrin conjugated to Alexa
Fluor 546 (50 μg/ml) for 1, 5 or 15 min at 28 °C. Binding
of human transferrin conjugated to Alexa Fluor 546 to
the epimastigote surfaces was performed by incubation
on ice for 30 min. To block the endocytic pathway, after
starvation, the epimastigotes were treated with 50 mM
ammonium chloride for 30 min at 28 °C. Then, human
transferrin conjugated to Alexa Fluor 546 was added to
the parasite suspension at 50 μg/ml and incubated for 1
or 5 min at 28 °C. Binding and endocytosis were halted
with 1 volume of cold 8 % formaldehyde in PHEM buf-
fer, and then the epimastigotes were centrifuged at 1500
g for 10 min and washed twice with PHEM buffer. The
parasites were adhered to poly-L-lysine-coated cover
slips, which were then incubated with DAPI, washed
with PHEM, mounted onto slides and observed using a
LEICA TCS-SP5 Confocal Laser Scanning Microscope
(CLSM, Leica Microsystems).
Immunoelectron microscopy
Dm28c-EGFP-TcCAT1.1 and Dm28c-WT epimastigotes
were harvested by centrifugation at 1500 g for 10 min
and washed with PHEM buffer, pH 7.3. The parasite
pellets were fixed in 0.2 % glutaraldehyde, 4 % parafor-
maldehyde, and 0.5 % picric acid in PHEM buffer for 1 h
at room temperature. They were then washed with
PHEM buffer and centrifuged at 2000 g for 10 min, in-
cubated with 100 mM glycine in PHEM buffer for 1 h
and washed twice with PHEM buffer, pH 7.3. Next, the
samples were dehydrated in ethanol at 4 °C, infiltrated
with unicryl resin (BB International, Ted Pella) at −20 °C
and polymerized under UV light for 120 h. Ultrathin
sections were prepared in nickel grids, and they were
incubated in blocking buffer composed of 1 % albumin,
0.02 % Tween20, and 0.5 % fish gelatin in PBS for 1 h.
Thin sections were subsequently incubated with 1:50anti-GFP diluted in blocking buffer for 2 h at room
temperature, washed and incubated with 15 nm gold-
conjugated goat anti-mouse IgG diluted 1:200 in blocking
buffer for 1 h at room temperature. Control reactions
using these primary and secondary antibodies were per-
formed with ultrathin sections of Dm28c-WT, and the
primary antibody was omitted in control reactions with
ultrathin sections of Dm28c-EGFP-TcCAT1.1. After ex-
tensive washing, the grids were stained with uranyl acet-
ate and lead citrate. Images of the ultrathin sections
were obtained with a Zeiss 900 transmission electron
microscope.
For electron microscopy, Dm28c-EGFP-TcCAT1.1,
and Dm28c-WT epimastigotes were fixed in 2.5 % glu-
taraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 1 h
at room temperature. They were then post-fixed in 1 %
osmium tetroxide and 0.8 % potassium ferrocyanide
in 0.1 M cacodylate buffer (pH 7.4) for 1 h at room
temperature, washed, dehydrated in acetone, and em-
bedded in Epon. The thin sections were stained with
uranyl acetate and lead citrate and observed using a
Zeiss 900 transmission electron microscope.
Results
TcCAT is a subfamily of the amino acid/auxin permease
(AAAP) family according to the Transporter Classifica-
tion Database (TCDB), a curated dataset resource com-
posed of transporter sequences from various organisms
[43]. The cationic amino acid transporter TcCAT sub-
family members from T. cruzi contain 4 ORFs distrib-
uted in three contigs, according to GeneDB [http://
www.genedb.org]. TcCLB.506153.10 (TcCAT1.1) and
TcCLB.506153.20 (TcCAT1.2) are located in the same
contig and share 100 % coding sequence identity;
however, TcCAT1.2 is located at the end of the contig,
suggesting that the missing 76 amino acid N-terminal re-
gion may have been lost due to a gap in the genome se-
quencing data, or to misassembly [44]. TcCLB.506053.10
(TcCAT1.3) is 99 % identical to TcCAT1.1, differing by
only one amino acid, possessing a Ser281 residue instead of
Ala281. The fourth isoform, TcCLB.511411.30, shares 98 %
identity with TcCAT1.1 and was recently identified as the
arginine transporter TcAAP3 from T. cruzi [45], displaying
six amino acid differences in the sequence alignment,
including three residues in the amino terminal region and
three within the transporter sequence, Ser281 to Ala281,
Phe327 to Leu327, and Lys
359 to Arg359.
TcCAT1.1 (TcCLB.506153.10 ORF), the isoform that
was chosen for functional characterization, possesses
43.6 % identity and 62.5 % similarity at the amino acid
level to the arginine transporter LdAAP3 from Leish-
mania donovani (Fig. 1a), and HMMTOP server 2.0
[http://www.enzim.hu/hmmtop] predicted that it con-
tains 10 transmembrane helices (Fig. 1b). Subsequently,
Fig. 1 TcCAT1.1 sequencing alignment and membrane topology. a Alignment between TcCAT1.1 from T. cruzi and LdAAP3 from L. donovani.
b Prediction of TcCAT1.1 membrane topology, as determined using HMMTOP server 2.0
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cus, the sodium-coupled neutral amino acid transporter,
and intracellular vacuolar amino acid transporters 2
(AVT2) and 6 (AVT6) from S. cerevisiae were found to
be high-scoring hits in a BLASTP search of the TCDB
database (~20 % identity and ~41 % similarity).
The TcCAT subfamily also shares 10 % identity and
23 % similarity at the amino acid level with the human
cationic amino acid transporters hCAT-1, hCAT-2A,and hCAT-3. The residues Glu369 and Asn381 are associ-
ated with increased affinity for L-ornithine, L-arginine,
and L-lysine in hCAT-1, hCAT-2B, and hCAT-3, and a
region of 80 amino acid sequences in length in hCAT
members is associated with trans-stimulation properties.
The human transporter isoform hCAT-2A, which dis-
plays lower affinity for substrates, has an Arg residue in
place of Glu369, and the Asn381 residue is missing [46].
The residues Glu369 and Asn381, which are responsible
Henriques et al. Parasites & Vectors  (2015) 8:346 Page 8 of 18for substrate affinity in hCAT members, were not identi-
fied in TcCAT1.1, suggesting that other amino acids are
responsible for substrate affinity and specificity.
Functional characterization in Saccharomyces cerevisiae
The TcCAT1.1 isoform, one of 4 nearly identical ORFs,
was selected for further functional characterization using
an S. cerevisiae mutant deficient in the following three
cationic amino acid transporters: Can1, which transports
arginine; Gap1, which transports all amino acids; and
Lyp1, the substrates of which are arginine and lysine.
To establish conditions for Km estimation, time-course
curves were generated for each substrate concentration
at 0, 0.5, 1, 2.5, 3, 5, and 10 min to assure that the assays
were performed within the linear range of substrate up-
take (Fig. 2a, b). To investigate relative affinity for argin-
ine, substrate saturation curves were generated using
TcCAT1.1-transformed yeast, and an apparent Km ofFig. 2 Substrate saturation curves for [3H]-arginine and [14C]-ornithine in th
curves in (●) galactose-induced and (○) glucose-repressed yeast cells. c and
[14C]-ornithine uptake rates in linear ranges. Data from control assays with
galactose-induced cells, and a Lineweaver-Burk plot of the data is shown in t
performed in triplicateapproximately 0.085 ± 0.04 mM and Vmax of 19.7 ± 9.3
pmol x 107 yeast−1 x min−1 were determined after three
trials (Fig. 2c). Ornithine, a lower-affinity substrate for
TcCAT1.1, displayed a Km in the range of 1.7 ± 0.2 mM
and a Vmax of 83 ± 58.4 pmol × 10
7 yeast−1 x min−1, as
determined after two trials (Fig. 2d). A comparison of
Vmax/Km revealed that arginine was a better substrate
than ornithine for TcCAT1.1 (Table 1). In the S. cerevi-
siae heterologous system, arginine uptake as mediated
by TcCAT1.1 was sensitive to changes in pH. Higher
rates of transport were observed at lower pH levels (pH
5 to 6.5), but at pH 8, the transport rate dropped to ap-
proximately 50 % of the maximal rate.
An initial screen for other possible substrates was
performed by conducting competition assays to assess
[3H]-arginine uptake with 100-fold excess of competitor
relative to the substrate concentration. Uptake of 10 μM
[3H]-arginine was used as a reference to estimate thee Saccharomyces cerevisiae expression system. a and b are time course
d depict the concentration dependence of the [3H]-arginine and
glucose-repressed cells were subtracted from those from assays with
he inset. The results are presented as the mean ± SD of one experiment
Table 2 Screening for potential substrates of TcCAT1.1 in
Saccharomyces cerevisiae
Competitor 1mM [3H]-Arginine uptake(%)
Arginine 18.3 ± 7.9
Canavanine 28.9 ± 6.3
Agmatine 86.1 ± 23.0
Ornithine 88.7 ± 6.4
Citrulline 106.8 ± 22.8
Homoarginine 65.5 ± 12.1
Lysine 78.0 ± 26.7
Histidine 67.3 ± 8.8
Aspartic acid 93.9 ± 5.6
Glutamic acid 93.2 ± 13.5
Asparagine 78.0 ± 6.1
Glutamine 74.2 ± 25.6
Proline 72.3 ± 12.1
Leucine 67.7 ± 16.2
Alanine 67.9 ± 2.6
Spermine 65.0 ± 6.6
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mM competitors after 30 min of incubation at room
temperature (see Table 2). This approach demonstrated
that canavanine is another possible substrate because it
competes with or inhibits approximately 70 % of argin-
ine uptake. The other tested compounds moderately
inhibited arginine uptake (<35 %), implying that they
might be lower-affinity substrates. For example, orni-
thine inhibited arginine uptake by 10 % and displayed an
apparent Km for uptake in the millimolar range (Tables 1
and 2). A variety of amino acids and other inhibitors
(methionine, cysteine, cysteic acid, phenylalanine, tyrosine,
tryptophan, β-alanine, isoleucine, 4-guanidino butyrate,
putrescine, spermidine, N-N dimethyl arginine, 2,3-dia-
mino propionic acid, 2,4-diamino-N-butyric acid, alpha
methyl amino isobutyric acid, N-methylaminoisobutyric
acid, 2-aminobicyclo heptane-2-carboxylic acid, 2,3-diami-
nopropionic acid, and pipecolic acid) were tested and
showed no competition/inhibition of arginine uptake by
TcCAT1.1. Notably, glutamine, asparagine, and histidine,
which are substrates for N-system transporters, and the
high-scoring hits determined by the BLAST search, were
not found to be the main substrates for TcCAT1.1
(Table 2).
To determine whether lysine was a potential substrate,
we attempted to directly measure [3H]-lysine uptake in
S. cerevisiae and in X. laevis oocytes, but found in-
creased background for [3H]-lysine in both systems. We
therefore performed competition assays of [3H]-arginine
uptake with 100-fold excess of cold lysine and found that
the uptake of 10 μM [3H]-arginine in the presence of 1
mM lysine was approximately 80 % of that without the
cold competitor (Table 2), suggesting that lysine could
be another lower-affinity substrate for TcCAT1.1, in
addition to ornithine.
Characterization in Xenopus laevis oocytes
Next, a series of experiments were performed using Xen-
opus oocytes to investigate whether TcCAT shares basic
properties with other previously characterized cationic
amino acid transporters. Trans-stimulation, attributable
to the stimulation of [3H]-arginine uptake by an intracel-
lular substrate, was observed in oocytes expressing
TcCAT1.1 (Fig. 3a). To investigate the magnitude of this
phenomenon, oocytes injected with TcCAT1.1 cRNA
and those injected with water were pre-loaded to equi-
librium by incubation with 1 mM arginine overnight orTable 1 Km and Vmax values for TcCAT1.1 expressed in
Saccharomyces cerevisiae
Substrate Vmax (pmol.10
7 yeast−1.min−1) Km (mM)
Arginine 19.7 ± 9.3 0.085 ± 0.04
Ornithine 83 ± 58.4 1.723 ± 0.2410 mM arginine for 6 h in ND96 buffer. The uptake of
radiolabeled [3H]-arginine in the pre-loaded oocytes was
approximately 7-fold higher in the TcCAT1.1-expressing
oocytes than in the controls. The oocytes that were not
pre-loaded with arginine displayed only a 2- to 3-fold in-
crease in [3H]-arginine uptake compared with the water-
injected oocytes (Fig. 3a). The trans-stimulation effect
was observed in the oocytes pre-loaded with arginine,
but not in those pre-loaded with lysine, leucine, or ala-
nine at 10 mM for 6 h. In the latter cases, [3H]-arginine
uptake was stimulated by only 2- to 3-fold in oocytes ex-
pressing TcCAT1.1 compared with that in the controls
(data not shown). The effect observed in the oocytes
pre-loaded with arginine suggests that the increased up-
take of [3H]-arginine is driven by arginine present on the
trans side of the membrane (Fig. 3a). The transport rate
was consistently higher in the oocytes expressing
TcCAT1.1 pre-loaded with arginine, reaching 3.65 ± 2.65
pmol x min−1, compared with that in the oocytes that
were not pre-loaded, in which it reached 0.60 ± 0.51
pmol x min−1 (n = 6). Arginine uptake driven by trans-
stimulation was observed with [3H]-arginine at 100, 250,
and 500 μM substrate concentrations (data not shown).
Next, the efflux of [3H]-arginine was investigated in
TcCAT1.1-expressing oocytes pre-loaded with 1 μM
[3H]-arginine. The time course of [3H]-arginine efflux in
oocytes that were pre-loaded for 6 h revealed a rate of
10 ± 2 fmol x min−1 in TcCAT1.1-expressing oocytes
and a rate of 0.6 ± 0.08 fmol x min−1 in water-injected
oocytes. In oocytes pre-loaded overnight with [3H]-ar-
ginine, the efflux rate was approximately 19 ± 3 fmol x
Fig. 3 Trans-stimulation in Xenopus laevis oocytes expressing
TcCAT1.1. Oocytes were pre-loaded overnight with 1 mM arginine.
Subsequently, uptake assays were performed by incubating oocytes
expressing TcCAT1.1 with 100 μM [3H]-arginine. a TcCAT1.1-injected
oocytes that were pre-loaded with arginine (●); TcCAT1.1-injected
oocytes that were not pre-loaded with arginine (▼); and water-injected
oocytes, used as controls (○). b Efflux of [3H]-arginine or arginine
sub-products from oocytes injected with TcCAT1.1 cRNA (●) and
from control oocytes injected with water (○). Oocytes were pre-loaded
for 6 h with 1 μM [3H]-arginine in ND96 buffer. c Effect of proton
uncouplers on [3H]-arginine uptake in pre-loaded oocytes
expressing TcCAT1.1
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x min−1 in controls. This rate remained linear for 3 h
and was at least 16-fold higher in the TcCAT1.1-express-
ing oocytes compared with that in the controls, which
were water-injected oocytes pre-incubated with [3H]-ar-
ginine (Fig. 3b).
To evaluate the effect of ionophores on [3H]-arginine
uptake as mediated by TcCAT1.1, oocytes pre-loaded
overnight with 1 mM arginine were pre-incubated for 20
min with 20 μM carbonyl cyanide m-chlorophenyl
hydrazone (CCCP; a proton ionophore), with 20 μM or
100 μM nigericin (a proton-potassium antiporter), or
with 100 μM ouabain (a sodium-potassium ATPase in-
hibitor) in ND96 buffer. Uptake assays were performed
for 30 min at room temperature with 100 μM [3H]-ar-
ginine in ND96 buffer in the presence of each of the
three compounds (Fig. 3c). The uptake of [3H]-arginine
was reduced by nigericin in a dose-dependent manner,
resulting in 34.3 ± 18.3 pmol x oocyte−1 (n = 3) for 20
μM nigericin and 11.1 ± 7.2 pmol x oocyte−1 (n = 3) for
100 μM nigericin compared with that of the controls,
which was 65.0 ± 6.4 pmol x oocytes−1 (n = 5). In the
presence of 20 μM CCCP, the level of [3H]-arginine up-
take was 17.1 ± 4.1 pmol x oocyte−1 (n = 4), and with 100
μM ouabain, it was 26.7 ± 11.4 pmol x oocyte−1 (n = 4).
The water-injected oocytes were subjected to the same
treatments, and the background was subtracted.
TcCAT subfamily expression during T. cruzi life cycle
The genes encoding members of the T. cruzi TcCAT
subfamily were found to be differentially expressed by
microarray analysis and qPCR. To evaluate gene expression
during the T. cruzi life cycle and during metacyclogenesis,
microarray data from three different metacyclogenesis ex-
periments were analyzed (biological replicas) using polyso-
mal RNA preparations that were hybridized at least twice
to the T. cruzi microarray (technical replicates). We ex-
amined the gene expression levels of TcCAT subfamily
members using three different probes, which all showed
overexpression of the epimastigote TcCAT genes under
nutritional stress and down regulated expression during
cellular differentiation. A comparison of the gene ex-
pression levels of the TcCAT subfamily members be-
tween epimastigotes and amastigotes by microarray
revealed no significant differences (Christian M. Probst,
personal communication).
To validate the data obtained by microarray and to
quantify TcCAT subfamily expression, we performed
qPCR using polysomal RNA prepared [47] from epimas-
tigotes that had been exposed to nutritional stress for 2
h in TAU medium, to trigger in vitro metacyclogenesis,
from parasites undergoing differentiation in TAU3AAG
medium for 3, 12, (12H) or 24 h, and from metacyclic
trypomastigotes. The values obtained were normalized
Henriques et al. Parasites & Vectors  (2015) 8:346 Page 11 of 18to those of the mRNAs encoding ribosomal L9 and his-
tone H2B. These results corroborated the previous
microarray results, demonstrating that when cells are ex-
posed to nutritional stress in TAU medium, which
mimics the urine of the triatomine host, these trans-
porters are upregulated, and the mRNA levels increase
after 2 h of starvation (Fig. 4). The expression of the
TcCAT subfamily members in epimastigotes under nu-
tritional stress varied during metacyclogenesis; however,
both experiments demonstrated increases in the levels of
mRNAs associated with polyribosomes. Protein expres-
sion is post-transcriptionally regulated in trypanosomes;
thus, we evaluated the levels of mRNAs associated with
polyribosome clusters, which are sites of protein synthe-
sis, and found increased expression of TcCAT subfamily
members.
In vitro and in vivo infection rates
To address the physiological contribution of TcCAT1.1
during the protozoan life cycle, an EGFP-TcCAT1.1 N-
terminal fusion construct was cloned into a pTREX vec-
tor and overexpressed in the Dm28c strain. Transgenic
Dm28c-EGFP-TcCAT1.1 epimastigotes were able to dif-
ferentiate into metacyclic trypomastigotes and infect
LLC-MK2 cells and mice. Evaluation of in vitro infection
of LLC-MK2 cells by optical microscopy of stained cells
demonstrated that transgenic parasites have similar rates
of infection to those of wild-type parasites, as evidenced
by the following findings: (1) after 24 h, Dm28c-EGFP-
TcCAT1.1 epimastigotes infected 16 to 25 % of the cells,
and Dm28c-WT epimastigotes infected 16 to 27 % ofFig. 4 Differential expression of TcCAT subfamily members as
determined by real-time polymerase chain reaction. Quantification
of polysome-associated mRNA expression during metacyclogenesis
>relative to that in epimastigotes in samples obtained from
metacyclogenesis experiment. Ribosomal L9(gray) and histone
H2B(black) were used as controls to normalize the expression of
polysomal mRNAs encoding TcCAT. EPI, replicating epimastigotes; STR,
nutritional stress; 3H, parasites after differentiation for 3 h; 12H, parasites
after differentiation for 12 h; 24H, parasites after differentiation for 24 h;
and MET, metacyclicsthe cells; and (2) after 48 h, these rates dropped to 11 to
24 % and 10 to 18 %, respectively. Indeed, once these
cells differentiated into amastigotes, they resumed nor-
mal proliferation comparable to that of wild-type para-
sites, and 1.2 to 1.4 amastigotes per infected cell were
detected for both strains (n = 2).
As a first step of characterizing infection in mice using
transgenic Dm28c-EGFP-TcCAT1.1 parasites, we com-
pared blood parasitemia in mice infected with transgenic
Dm28c-EGFP-TcCAT1.1 and Dm28c-WT trypomasti-
gotes, and transgenic Dm28c-EGFP was used as a con-
trol. Mice infected with the wild-type strain and with
Dm28c-EGFP showed a typical parasitemia curve, which
increased up to 20 dpi to 3.7 ± 2.0 × 105 and 5.0 ± 2.2 ×
105 trypomastigotes/ml, respectively (n = 6). However,
in the mice infected with transgenic Dm28c-EGFP-
TcCAT1.1 trypomastigotes, parasitemia was lower at 20
dpi, with 6.0 ± 3.9 × 104 trypomastigotes/ml (n = 5) but
with patent levels of circulating parasites at all time
points (not shown), indicative of active infection. Thus,
the course of infection may vary between transgenic
parasites expressing only EGFP and those expressing
EGFP-TcCAT1.1.
TcCAT1.1 localization in T. cruzi and arginine uptake in
T. cruzi expressing EGFP-TcCAT1.1
The EGFP-TcCAT1.1 fusion construct was expressed in
Dm28c because of its high efficiency of in vitro metacy-
clogenesis. Expression of the Dm28c-EGFP-TcCAT1.1
chimera was apparent in epimastigotes (Fig. 5a) and
intracellular amastigotes (not shown) but was faint in
trypomastigotes (not shown), as visualized by fluores-
cence microscopy, consistent with TcCAT subfamily ex-
pression throughout the T. cruzi life cycle, as evaluated
by qPCR (Fig. 4). TcCAT1.1 was not expressed in acido-
calcisomes, as observed by fluorescence microscopy, and
it did not co-localize with the vacuolar-type proton-
pumping pyrophosphatase (PPase; not shown); however,
we cannot discount the fact that other isoforms that are
TcCAT subfamily members are expressed in acidocalci-
somes. As illustrated in Fig. 5, EGFP-TcCAT1.1 labeling
was predominant in the anterior regions of epimasti-
gotes, and its position relative to the DAPI-stained
nucleus and kinetoplast indicated that TcCAT1.1 was
located near the flagellar pocket, Golgi complex, and
spongiome region, which is a network of vesicles and
tubules (Fig. 5a) [48]. Incubation with anti-EGFP rein-
forced this localization but revealed its distribution in
other intracellular compartments, including the endo-
plasmic reticulum (Fig. 5b).
The site of EGFP-TcCAT1.1 expression in the anterior
epimastigote region is also where endo- and exocytosis
occur; thus, we performed transferrin-Alexa Fluor 546
uptake experiments to verify its co-localization with the
Fig. 5 (See legend on next page.)
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Fig. 5 Localization of EGFP-TcCAT1.1 in Trypanosoma cruzi. Stable transfectants of Dm28c over-expressing EGFP-TcCAT1.1 were cloned and maintained
in 500 μg/ml of G418. Expression was evaluated by confocal microscopy. Panel (a) shows the intracellular distribution of EGFP-TcCAT1.1 at the anterior
regions of the parasite (arrows). Panel (b) shows additional sites of reduced expression following incubation with anti-GFP, including the epimastigote
surface (arrow head). Panels (c) and (d) show endocytosis with transferrin-Alexa Fluor 546 (small arrow) after 1 min in ammonium chloride-treated
epimastigotes (c) and after 15 min (d). Panels (e) and (f) show the results of labeling with anti-RAB7 (small arrow) to evaluate co-localization of
EGFP-TcCAT1.1 (arrow) with the Golgi complex. The left column shows differential interference contrast microscopy, the central column depicts
EGFP-TcCAT1.1 expression (green), and the right column shows DAPI labeling of the nucleus and kinetoplast (blue), anti-RAB7, and transferrin-Alexa
Fluor 546 tracer (red). N, nucleus; K, kinetoplast; FP, flagellar pocket
Fig. 6 Ultrastructural localization of EGFP-TcCAT1.1. Stable transfectants of Dm28c epimastigotes over-expressing EGFP-TcCAT1.1 were evaluated
by transmission electron microscopy. a Ultrastructural organization of the epimastigote anterior region embedded in epoxy resin. b-d Immunoelectron
microscopy to evaluate EGFP-TcCAT1.1 localization in the spongiome region, as observed by gold particle distribution (arrow), after incubation
with anti-GFP. N, nucleus; K, kinetoplast; FP, flagellar pocket; Go, Golgi complex; Sp, spongiome; Cy, cytostome
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transferrin-Alexa Fluor 546, conjugated transferrin was
found in the cytostome, cytophraynx, and early endo-
some, as previously described [49]. However, it did not
co-localize with EGFP-TcCAT1.1 (Fig. 5c, d). In epimas-
tigotes expressing EGFP-TcCAT1.1, the intracellular la-
beling near the Golgi complex in the anterior region was
duplicated during cell division (Fig. 5b), as observed for
the GTPase TcRAB7 protein expressed in the Golgi of
T. cruzi [42]. TcRAB7 labeling was punctuate and was in
close vicinity to that of EGFP-TcCAT1.1, juxtaposed to the
Golgi complex in vesicles; however, their co-localization
was not conclusive (Figs. 5e-f and 6a). EGFP-TcCAT1.1
expression was not observed in the flagellar pocket, cytos-
tome, or Golgi complex, as demonstrated by confocal mi-
croscopy (Fig. 5c-f) and immunoelectron microscopy
(Fig. 6b-d), and it was mainly found in vesicles at the anter-
ior region, comprising vesicles or lamellae of the spon-
giome or multivesicular bodies [48]. Importantly,
TcCAT1.1 is also expressed in other compartments
and in regions of the plasma membrane (Fig. 5b),
which could explain the 2- to 3-fold higher uptake of
100 μM [3H]-arginine in two clones of Dm28c epimas-
tigotes over-expressing EGFP-TcCAT1 compared with
that of the controls, which included EGFP-expressing
Dm28c and wild-type Dm28c (Fig. 7).
Discussion
Functional characterization in heterologous systems
In T. cruzi, most studies of transport systems have
focused on global measurements of cellular uptake, and
few have characterized the molecular mechanisms under-
lying these activities by performing molecular cloning and
functional characterization in heterologous systems.
Herein, we describe the molecular characterization of aFig. 7 Time course curve of [3H]-arginine in Trypanosoma cruzi
epimastigotes. [3H]-arginine uptake was evaluated in two clones of
transgenic Dm28c EGFP-TcCAT1.1 epimastigotes (■,▼), in WT
Dm28c (◊), and in transgenic Dm28c-EGFP, used as a control (○)novel intracellular arginine/ornithine transporter from
T. cruzi, TcCAT1.1, a member of the cationic amino acid
transporter subfamily TcCAT, which displays high affinity
for arginine (Km on the order of 0.085 mM) and lower
affinities for other cationic amino acids, such as ornithine
(Km of 1.7 mM) (Fig. 2). The intracellular concentration of
L-arginine in human tissues is in the millimolar range
(0.1-1 mM) and depends on the cell type, and the plasma
levels range from 0.040 to 0.115 mM [50], which is within
the range of Km values estimated for arginine uptake by
TcCAT1.1.
The most relevant arginine transport system in mam-
mals is the Na+-independent high-affinity y + system,
which includes four well-characterized cationic amino acid
transporters, CAT-1, CAT-2A, CAT-2B, and CAT-3. The
Km values are estimated to be between 70 and 250 μM for
L-arginine, L-ornithine, and L-lysine for CAT-1, 40 and
380 μM for CAT-2B, and 2 to 5 mM for CAT-2A when
they are expressed in Xenopus laevis oocytes [50–55]. We
have previously shown that the apparent Km can vary
depending on the system used for functional studies [56]
but that the apparent affinity of TcCAT1.1 for arginine
closely resembles its affinities for CAT-1 and CAT-2B.
TcCAT1.1 displays several distinct properties com-
pared with the hCAT cationic amino acid transporter
family (hCAT-1, hCAT-2A, hCAT-2B, and hCAT-3), and
it can thus be explored as a strategy for chemotherapy.
Unlike hCATs, which bind with high affinity to several
basic amino acids, TcCAT1.1 binds with high affinity to
L-arginine. Ornithine and possibly lysine are low-affinity
substrates for TcCAT1.1 in T. cruzi, as inferred from
competition studies performed in S. cerevisiae expressing
TcCAT1.1 (Table 2). Canavanine is another possible sub-
strate for TcCAT1.1, and it competes effectively with
arginine, resulting in 70 % inhibition of arginine uptake
(Table 1). Canavanine is an example of a plant-derived
product because it is an arginine analog found primarily
in the seeds of certain leguminous plants. It displays
cytostatic and anti-proliferative effects in T. cruzi epi-
mastigote cultures, incorporating into proteins, causing
them to be non-functional and structurally aberrant
[57]. Moreover, unlike CAT-2B, which shows only 50 %
activity at low pH [52], TcCAT1.1 is highly active at a
broad range of acidic to neutral pH levels (data not
shown), and this broad range of activity can be physiolo-
gically important for a transporter that operates as an
exchanger and is located in intracellular compartments.
Similar findings have been observed for arginine trans-
port mediated by the LdAAP3 transporter from Leish-
mania donovani, which displays optimum activity at pH
5.0, the acidic pH level of the parasitophorous vacuole
compartment [27]. Indeed, in oocytes, arginine uptake as
mediated by TcCAT1.1 was affected by nigericin, a Na+/H+
exchanger, and was reduced by 70 % by the ionophore
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with the yeast vacuolar transporters AVT1-7 [58] and
plant/auxin amino acid permeases (AAAP family) from
Arabidopsis thaliana, which actively transport amino acids
into plant cells by an amino acid/H+ symport mechanism
[59].
TcCAT1.1 is also involved in the trans-stimulation of
arginine uptake, and substrate accumulation is activated
by the presence of intracellular substrate (Fig. 3a). This
characteristic property has been reported previously for
members of the human CAT family and for the hetero-
dimeric amino acid transporter hF2hc/y+LAT2 [52, 60,
61]. Xenopus oocytes actively synthesize proteins; thus,
some of the accumulated intracellular arginine can be
incorporated into proteins, complicating estimation of
the precise concentration of intracellular arginine avail-
able for exchange. Nevertheless, the influx rate was con-
sistently more robust in TcCAT1.1-expressing oocytes
that were pre-loaded with arginine (Fig. 3a). Arginine
influx was in the pmol x min−1 range, and equilibrium was
achieved after 3 h, whereas the outward flux capacity for
arginine was 1000-fold lower (Fig. 3b). Investigating the
parameters of arginine efflux in greater detail, including
the binding and translocation of substrates from the intra-
cellular side of the membrane, will require more readily
manipulatable systems, such as plasma membrane vesicles
isolated from S. cerevisiae, T. cruzi over-expressing the
TcCAT1.1 transporter, and liposomes.
Evaluation of TcCAT1.1 expression in Trypanosoma cruzi
TcCAT subfamily mRNA was consistently more abun-
dant in epimastigotes under nutritional stress compared
with that in those cultivated in regular medium and in
metacyclic trypomastigotes (Fig. 4), suggesting that
stage-specific expression is the result of differential
mobilization of mRNAs to the polysome fraction, as has
been described for other T. cruzi genes [62]. Upregula-
tion of TcCAT subfamily members in epimastigotes
subjected to starvation can be important for the main-
tenance of arginine homeostasis during metacyclogenesis
and the translocation of arginine from intracellular
pools, such as the acidocalcisomes, reservosomes, and
other intracellular compartments. Similarly, expression
of the LdAAP3 transporter and its transcripts in L.
donovani has been shown to increase as a function of
the durations of starvation and arginine deprivation, ran-
ging from 2 to 4 h, and it is correlated with decreases in
the intracellular levels of most amino acids, including
arginine [63]. Further, starvation of mammalian cells for
amino acids has been shown to enhance CAT-1 activity
by increasing CAT-1 mRNA stability and translation [64,
65], thereby increasing CAT-1 abundance.
The differences in arginine metabolism between the
human host and T. cruzi are associated with the fact thatthe protozoa have no capacity for arginine biosynthesis,
causing it to be entirely dependent on transporters to
acquire this amino acid from the environment. As a con-
sequence, it is more vulnerable than host cells to drugs
that block or interfere with arginine metabolism or dis-
rupt its transport. Importantly, there are some particu-
larities of arginine metabolism in T. cruzi compared
with its mammalian host and Leishmania species. In T.
cruzi, arginine is converted to phosphorylated arginine
in a reaction catalyzed by arginine kinase, an enzyme
that is not known to exist in Leishmania. However, in
contrast with the biosynthetic pathways of Leishmania,
polyamine biosynthesis in T. cruzi remains controversial
because this parasite lacks the enzyme ornithine decarb-
oxylase, and there is conflicting evidence about whether
polyamine biosynthesis occurs via arginine decarboxyl-
ase [66–68].
Some intracellular compartments serve as storage
sites, and arginine and lysine constitute approximately
90 % of the total amino acids in T. cruzi acidocalcisomes
[22]. However, other compartments of arginine metabol-
ism also contain arginine pools, such as the reservosome
and possibly other vesicles and tubules that have not yet
been identified, and they represent sites of storage and
maintenance of intracellular arginine pools. During
metacyclogenesis, TcCAT subfamily expression is upreg-
ulated; however, identification of the intracellular locali-
zations of the isoforms TcCAT1.1, TcCAT1.2, and
TcCAT1.3 is crucial for the understanding of the dynam-
ics of arginine mobilization under stress conditions and
to reveal the locations of other intracellular pools of
arginine. To determine the cellular localization of the
TcCAT1.1 isoform, EGFP was fused to the N-terminal
region of the transporter. Overexpression of this fusion
protein in epimastigotes resulted in intracellular labeling
observed mainly at the anterior regions of epimastigotes
(Fig. 5). A comparison of the pattern of EGFP fluo-
rescence with that of DAPI labeling indicated that
TcCAT1.1 was located adjacent to the nucleus and very
close to the flagellar pocket. The Golgi complex and the
endocytic pathway were excluded as sites of TcCAT1.1
expression (Fig. 5c-f). Because few antibodies can be
used to identify discrete compartments, we used elec-
tron microscopy and immunocytochemistry to deter-
mine the precise localization. The flagellar pocket and
Golgi complex were excluded as the expression sites of
this transporter; however, a network of tubules and vesi-
cles called the spongiome was observed by immunocyto-
chemistry and is a candidate location of TcCAT1.1
isoform expression (Fig. 6). The spongiome and its sur-
rounding area have been recently described, and its
ultrastructure has been elucidated by high-pressure
freezing and electron tomography [48]. This region is
associated with the intense trafficking of vesicles and
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Other transporters have been reported to be localized to
the anterior region of this parasite, for example, two
polyamine transporters have been found in the network
of vesicles and tubules surrounding the contractile vacu-
ole [30], and the TcABC1 exchanger has also been
identified in this region [26]. Similar to the TcABC1
transporter, which is distributed in intracellular compart-
ments and in regions of the T. cruzi plasma membrane
[26], TcCAT1.1 is also expressed in different regions, in-
cluding intracellular compartments and at lower levels
in the plasma membrane. This membrane localization
could explain the [3H]-arginine uptake that was observed
following expression of EGFP-TcCAT1.1 by whole epimas-
tigotes (Fig. 7).
Conclusions
Substrate affinity, trans-stimulation, and the kinetic
parameters of arginine/ornithine transport estimated for
TcCAT1.1 can be extended to other TcCAT subfamily
members, such as TcCAT1.2, TcCAT1.3, and TcAAP3.
Previous characterization of the TcAAP3 transporter has
revealed that it is also an arginine transporter that is
expressed in the anterior region of epimastigotes. Intra-
cellular expression is an important characteristic of
members of the TcCAT subfamily of cationic amino acid
transporters, and it could account for their translocation
of intracellular pools of cationic amino acids. Members
of this transporter subfamily characteristically function as
exchangers, consistent with the intracellular localization of
the TcCAT1.1 isoform, and its up-regulation under
nutritional stress suggests that TcCAT transporters are
candidates for regulation of cellular homeostasis during
metacyclogenesis and during the T. cruzi life cycle. The
complexity of the expression of the transporters re-
quired to obtain arginine and cationic amino acids from
the environment is associated with their importance to
T. cruzi biology. We have performed a BLAST search,
identifying 26 putative amino acid transporters. In
addition, we have identified another arginine permease
in the T. cruzi genome using a genome database of an-
notated sequences [http://www.genedb.org/]; thus, it is
reasonable to propose that there might be additional
cationic amino acid transporters in T. cruzi. An increase
in the number of transporters cloned and characterized
from T. cruzi will provide new insights into the contri-
butions of various transporters to the metabolism of
cationic amino acids throughout the life cycle of this
parasite.
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